West Pharmaceutical Services Inc (WST)
338.12
-5.88
(-1.71%)
USD |
NYSE |
Nov 14, 16:00
332.71
-5.41
(-1.60%)
Pre-Market: 07:22
West Pharmaceutical Services Free Cash Flow (Quarterly): 98.80M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 98.80M |
| June 30, 2024 | 64.80M |
| March 31, 2024 | 27.60M |
| December 31, 2023 | 130.40M |
| September 30, 2023 | 134.30M |
| June 30, 2023 | 93.80M |
| March 31, 2023 | 56.00M |
| December 31, 2022 | 135.90M |
| September 30, 2022 | 111.10M |
| June 30, 2022 | 107.00M |
| March 31, 2022 | 85.40M |
| December 31, 2021 | 84.30M |
| September 30, 2021 | 124.80M |
| June 30, 2021 | 87.50M |
| March 31, 2021 | 34.00M |
| December 31, 2020 | 94.80M |
| September 30, 2020 | 71.10M |
| June 30, 2020 | 107.20M |
| March 31, 2020 | 25.00M |
| December 31, 2019 | 68.80M |
| September 30, 2019 | 76.40M |
| June 30, 2019 | 76.80M |
| March 31, 2019 | 18.80M |
| December 31, 2018 | 43.20M |
| September 30, 2018 | 61.90M |
| Date | Value |
|---|---|
| June 30, 2018 | 61.80M |
| March 31, 2018 | 17.00M |
| December 31, 2017 | 52.00M |
| September 30, 2017 | 41.50M |
| June 30, 2017 | 55.80M |
| March 31, 2017 | -16.80M |
| December 31, 2016 | 24.30M |
| September 30, 2016 | 19.70M |
| June 30, 2016 | 41.20M |
| March 31, 2016 | -36.00M |
| December 31, 2015 | 23.20M |
| September 30, 2015 | 39.10M |
| June 30, 2015 | 50.80M |
| March 31, 2015 | -32.30M |
| December 31, 2014 | 18.70M |
| September 30, 2014 | 35.30M |
| June 30, 2014 | 39.70M |
| March 31, 2014 | -22.90M |
| December 31, 2013 | 26.10M |
| September 30, 2013 | 24.00M |
| June 30, 2013 | 57.40M |
| March 31, 2013 | -42.80M |
| December 31, 2012 | 36.20M |
| September 30, 2012 | 22.60M |
| June 30, 2012 | 15.20M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
25.00M
Minimum
Mar 2020
135.90M
Maximum
Dec 2022
87.13M
Average
90.65M
Median
Free Cash Flow (Quarterly) Benchmarks
| Repligen Corp | 34.79M |
| Perspective Therapeutics Inc | -9.917M |
| Retractable Technologies Inc | -2.824M |
| Xtant Medical Holdings Inc | -5.652M |
| Catheter Precision Inc | -1.742M |